References

Global Burden of Cardiovascular Diseases and Risk Factors, 1990‐2019: Update From the GBD 2019 Study

2020 · External reference

Multimorbidity

10.1038/s41572-022-00376-4 · 2022 · External reference

Aging and Cardiovascular Health: CVIA State‐of‐the‐Art Review

2026 · External reference

Association of Cardiometabolic Multimorbidity With Mortality

10.1001/jama.2015.7008 · 2015 · External reference

Integrated Metabolic and Inflammatory Clustering Reveals Distinct Risk Profiles for Digestive Diseases

10.1002/advs.202511000 · 2025 · External reference

UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age

10.1371/journal.pmed.1001779 · 2015 · External reference

A Performance‐Driven Benchmark for Feature Selection in Tabular Deep Learning

2023 · External reference

Multicollinearity and Misleading Statistical Results

10.4097/kja.19087 · 2019 · External reference

Atlas of Plasma NMR Biomarkers for Health and Disease in 118,461 Individuals From the UK Biobank

10.1038/s41467-023-36231-7 · 2023 · External reference

Regularization Paths for Cox's Proportional Hazards Model via Coordinate Descent

10.18637/jss.v039.i05 · 2011 · External reference

Multivariable Prognostic Models: Issues in Developing Models, Evaluating Assumptions and Adequacy, and Measuring and Reducing Errors

10.1002/(sici)1097-0258(19960229)15:4<361::aid-sim168>3.0.co;2-4 · 1996 · External reference

Assessment and Comparison of Prognostic Classification Schemes for Survival Data

10.1002/(sici)1097-0258(19990915/30)18:17/18<2529::aid-sim274>3.0.co;2-5 · 1999 · External reference

Plasma Proteomic Associations With Genetics and Health in the UK Biobank

10.1038/s41586-023-06592-6 · 2023 · External reference

Tutorial in Biostatistics: Competing Risks and Multi‐State Models

10.1002/sim.2712 · 2007 · External reference

Proportional Hazards Tests and Diagnostics Based on Weighted Residuals

10.1093/biomet/81.3.515 · 1994 · External reference

Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing

10.1111/j.2517-6161.1995.tb02031.x · 1995 · External reference

The Lasso Method for Variable Selection in the Cox Model

10.1002/(sici)1097-0258(19970228)16:4<385::aid-sim380>3.0.co;2-3 · 1997 · External reference

Multiple Imputation Using Chained Equations: Issues and Guidance for Practice

10.1002/sim.4067 · 2011 · External reference

Prognostic Value of Grip Strength: Findings From the Prospective Urban Rural Epidemiology (PURE) Study

10.1016/s0140-6736(14)62000-6 · 2015 · External reference

Gamma Glutamyl Transferase and Metabolic Syndrome, Cardiovascular Disease, and Mortality Risk: The Framingham Heart Study

10.1161/01.atv.0000251993.20372.40 · 2007 · External reference

Cystatin C Versus Creatinine in Determining Risk Based on Kidney Function

10.1056/nejmoa1214234 · 2013 · External reference

Apolipoprotein B Particles and Cardiovascular Disease: A Narrative Review

10.1001/jamacardio.2019.3780 · 2019 · External reference

Triglyceride‐Glucose Index and Triglyceride to High‐Density Lipoprotein Cholesterol Ratio as Potential Cardiovascular Disease Risk Factors: An Analysis of UK Biobank Data

10.1186/s12933-023-01762-2 · 2023 · External reference

C‐Reactive Protein Concentration and Risk of Coronary Heart Disease, Stroke, and Mortality: An Individual Participant Meta‐Analysis

10.1016/s0140-6736(09)61717-7 · 2010 · External reference

Body Roundness Index and All‐Cause Mortality Among US Adults

10.1001/jamanetworkopen.2024.15051 · 2024 · External reference

Sex‐Specific Risks for Cardiovascular Disease Across the Glycaemic Spectrum: A Population‐Based Cohort Study Using the UK Biobank

10.1016/j.lanepe.2023.100693 · 2023 · External reference

Cardiovascular Disease in Chronic Kidney Disease: Pathophysiological Insights and Therapeutic Options

10.1161/circulationaha.120.050686 · 2021 · External reference

Associations Between Multimorbidity and the Risks of Cardiovascular Disease Events and All‐Cause Mortality in Patients With Chronic Kidney Disease

10.1159/000544722 · 2025 · External reference

Triglyceride‐Glucose Index, Renal Function and Cardiovascular Disease: A National Cohort Study

10.1186/s12933-023-02055-4 · 2023 · External reference

Associations Between Measures of Sarcopenic Obesity and Risk of Cardiovascular Disease and Mortality: A Cohort Study and Mendelian Randomization Analysis Using the UK Biobank

10.1161/jaha.118.011638 · 2019 · External reference

The Obesity Paradox in ST‐Segment Elevation Myocardial Infarction Patients: A Meta‐Analysis

10.1111/anec.13022 · 2023 · External reference

Chronic Kidney Disease, Insulin Resistance, and Incident Diabetes in Older Adults

10.2215/cjn.11861111 · 2012 · External reference

Stroke Mortality and the apoB/apoA‐I Ratio: Results of the AMORIS Prospective Study

10.1111/j.1365-2796.2005.01610.x · 2006 · External reference

Systematic Analysis of the Burden of Ischemic Stroke Attributable to High LDL‐C From 1990 to 2021

10.3389/fneur.2025.1547714 · 2025 · External reference

Molecular Links and Clinical Effects of Inflammation and Metabolic Background on Ischemic Stroke: An Update Review

10.3390/jcm13247515 · 2024 · External reference

Triglycerides, Triglyceride‐Rich Lipoproteins, and Remnant Cholesterol in Atherosclerotic Cardiovascular Disease

10.12997/jla.2025.14.3.247 · 2025 · External reference

Cholesterol Remnants, Triglyceride‐Rich Lipoproteins and Cardiovascular Risk

10.3390/ijms24054268 · 2023 · External reference

High‐Density Lipoprotein in Cardiovascular Diseases: From High Quantity to High Quality

10.1016/j.cca.2025.120574 · 2026 · External reference

VLDL Biogenesis and Secretion: It Takes a Village

10.1161/circresaha.123.323284 · 2024 · External reference

A Novel Protein Glycan Biomarker and Future Cardiovascular Disease Events

10.1161/jaha.114.001221 · 2014 · External reference

Amino Acid Regulation in Metabolic Heart Disease: Mechanisms and Therapeutic Potential

2026 · External reference

Metabolite Profiles and the Risk of Developing Diabetes

10.1038/nm.2307 · 2011 · External reference

Association Patterns of Ketone Bodies With the Risk of Adverse Outcomes According to Diabetes Status

2024 · External reference

Higher Ratio of Plasma Omega‐6/Omega‐3 Fatty Acids Is Associated With Greater Risk of All‐Cause, Cancer, and Cardiovascular Mortality: A Population‐Based Cohort Study in UK Biobank

10.7554/elife.90132 · 2024 · External reference

The Complement System in Human Cardiometabolic Disease

10.1016/j.molimm.2014.06.031 · 2014 · External reference

Haemostasis and Innate Immunity—A Complementary Relationship: A Review of the Intricate Relationship Between Coagulation and Complement Pathways

10.1111/bjh.15062 · 2018 · External reference

Extracellular Matrix Remodeling in Obesity and Metabolic Disorders

10.1093/lifemeta/load021 · 2023 · External reference

Matrix Metalloproteinases, Vascular Remodeling, and Vascular Disease

10.1016/bs.apha.2017.08.002 · 2018 · External reference